All Updates

West Virginia has the highest adult smoking rate in the country, over 28% of West Virginia high school students use tobacco products, including e-cigarettes, and nearly 38% of cancer deaths can be attributed to smoking in the state, the highest smoking-attributable cancer death rate in the country.

Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA) publicó una norma propuesta sobre las etiquetas de información nutricional en el frente del paquete (FOP, por sus siglas en inglés), que obligaría a incluir un recuadro de información nutricional en el frente de los paquetes de alimentos para complementar la etiqueta de información nutricional ya requerida.

Un nuevo informe (en inglés) de la Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer (ACS CAN) descubrió que más del 70% de los pacientes con seguro comercial tuvieron gastos de bolsillo para pruebas de diagnóstico de seguimiento del cáncer de mama en 2023.

COLUMBIA, S.C. – As the 2025 legislative session begins Tuesday, the American Cancer Society Cancer Action Network (ACS CAN) urges lawmakers to support policies that will reduce the cancer burden in the Palmetto State. ACS CAN South Carolina Government Relations Director Beth Johnson released the following statement: “We

NASHVILLE, Tenn. – As Tennessee lawmakers begin the 2025 legislative session Tuesday, the American Cancer Society Cancer Action Network (ACS CAN) urges them to prioritize legislation which would allow more Tennesseans to access biomarker testing, an increasingly important part of cancer care. In the case of a cancer

Un nuevo informe (en inglés) de la Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer (ACS CAN) descubrió que más del 70% de los pacientes con seguro comercial tuvieron gastos de bolsillo para pruebas de diagnóstico de seguimiento del cáncer de mama en 2023.

A new report by the American Cancer Society Cancer Action Network (ACS CAN) found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in 2023. These follow-up tests, such as a diagnostic mammogram, MRI, ultrasound or biopsy, are medically recommended next steps to determine if an individual may or may not have cancer; however, barriers like cost can keep people from getting them.

OLYMPIA, Wash. -- As Washington legislators convene today for a new session, American Cancer Society Cancer Action Network advocates will ask them to prioritize patients' ready access to needed and proven biomarker testing. Biomarker testing is about identifying the most effective treatment for patients with cancer and other serious illnesses.

A new report by the American Cancer Society Cancer Action Network (ACS CAN) found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in 2023. These follow-up tests, such as a diagnostic mammogram, MRI, ultrasound or biopsy, are medically recommended next steps to determine if an individual may or may not have cancer; however, barriers like cost can keep people from getting them.